195 related articles for article (PubMed ID: 36306450)
21. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
22. Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro.
Li X; Wang C; Chen J; Hu X; Zhang H; Li Z; Lan B; Zhang W; Su Y; Zhang C
Toxicol Lett; 2022 Apr; 358():40-47. PubMed ID: 35063619
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Sweated and Non-Sweated Ethanol Extracts of
Liu J; Shi Y; Wu C; Hong B; Peng D; Yu N; Wang G; Wang L; Chen W
Curr Drug Metab; 2022; 23(6):473-483. PubMed ID: 35585828
[TBL] [Abstract][Full Text] [Related]
24. In vitro effects of opicapone on activity of human UDP-glucuronosyltransferases isoforms.
Wang Z; Wang Z; Wang X; Lv X; Yin H; Fan X; Yan M; Jia Y; Jiang L; Xia Y; Li W; Liu Y
Toxicol Lett; 2022 Aug; 367():3-8. PubMed ID: 35810997
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
Toxicol Appl Pharmacol; 2023 May; 466():116490. PubMed ID: 36963523
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactions.
Wang Z; Wang X; Jia Y; Yin H; Feng Y; Jiang L; Cao J; Liu Y
Biopharm Drug Dispos; 2020 Jun; 41(6):231-238. PubMed ID: 32436276
[TBL] [Abstract][Full Text] [Related]
27. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO
Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975
[TBL] [Abstract][Full Text] [Related]
28. Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids.
Singh R; Wu B; Tang L; Hu M
J Agric Food Chem; 2011 Jul; 59(13):7452-64. PubMed ID: 21413806
[TBL] [Abstract][Full Text] [Related]
29. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8.
Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2006; 31(4):299-309. PubMed ID: 17315542
[TBL] [Abstract][Full Text] [Related]
30. Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation.
Busse D; Leandersson S; Amberntsson S; Darnell M; Hilgendorf C
J Pharm Sci; 2020 Jul; 109(7):2309-2320. PubMed ID: 32294459
[TBL] [Abstract][Full Text] [Related]
31. Human UDP-Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol.
Zhu L; Xiao L; Li W; Zhang Y; Han W; Zhu Y; Ge G; Yang L
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):505-511. PubMed ID: 27176228
[TBL] [Abstract][Full Text] [Related]
32. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
33. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms.
Teng Y; Nian H; Zhao H; Chen P; Wang G
Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345
[TBL] [Abstract][Full Text] [Related]
34. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
Ruan JQ; Yan R
Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
[TBL] [Abstract][Full Text] [Related]
35. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
Malfatti MA; Felton JS
Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
[TBL] [Abstract][Full Text] [Related]
36. An investigation of the metabolic activity, isozyme contribution, species differences and potential drug-drug interactions of PI-103, and the identification of efflux transporters for PI-103-
Gao L; Qin Z; Zhang B; Yin Z; Zhang X; Yang J
RSC Adv; 2020 Mar; 10(16):9610-9622. PubMed ID: 35497201
[TBL] [Abstract][Full Text] [Related]
37. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
[TBL] [Abstract][Full Text] [Related]
38. Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes.
Jiang L; Zhang Z; Xia Y; Wang Z; Wang X; Wang S; Wang Z; Liu Y
Toxicol Lett; 2020 Mar; 320():46-51. PubMed ID: 31812603
[TBL] [Abstract][Full Text] [Related]
39. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
Aprile S; Del Grosso E; Grosa G
Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of UDP-glucuronosyltransferases (UGTs) by phthalate monoesters.
Du Z; Cao YF; Li SN; Hu CM; Fu ZW; Huang CT; Sun XY; Liu YZ; Yang K; Fang ZZ
Chemosphere; 2018 Apr; 197():7-13. PubMed ID: 29328989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
